Figure skaters with disabilities seek a place in the Paralympic spotlight

Now she’s part of a movement hoping to get figure skating into the Paralympics. Skating sports are a big gap on the program when the Winter Paralympics start on Friday. Figure skaters with ...

Colleges See Spike in Students With Disabilities, Including Elite Schools

Universities from Harvard to Hampshire have admitted significantly more students with disabilities over the last decade, as diagnoses for A.D.H.D. and anxiety increase.
The Hindu

Preventing Multiple Sclerosis from progressing to long-term disability

India struggles with a high prevalence of autoimmune diseases that eventually lead to chronic illnesses in approximately 5% to 8% of the country’s total population. Among these, Multiple Sclerosis (MS ...
FierceBiotech

Roche unveils data behind BTK inhibitor's phase 3 multiple sclerosis win in Ocrevus trial

Roche has shared the numbers behind its phase 3 win in primary progressive multiple sclerosis (PPMS), linking its BTK inhibitor to a 12% reduction in the risk of disability progression compared to ...

TN kids with disabilities face a justice system not designed for them

Two cases involving Tennessee children with autism illustrate the harsh, complex realities they face in the juvenile justice ...
Seeking Alpha

Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS)

– Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the current standard of care, Ocrevus, in ...
Morningstar

Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS)

Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS) – Late-breaking Phase III FENtrepid ...
Rutland Herald

Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS)

Therefore, an important goal of treating multiple sclerosis is to slow, stop and ideally prevent progression as early as possible. Approximately 85% of people with multiple sclerosis have a relapsing ...
The New Indian Express

Economic Survey cites Odisha as top example across multiple sectors

BHUBANESWAR : Probably for the first time, Odisha was frequently cited in the Economic Survey (2025-26) for policy innovations and on-ground outcomes shaping key reforms on growth, resilience and ...
Leicester Mercury

‘Serious concerns’ raised over council plans to close multiple SEND nurseries

“Serious concerns” have been raised over proposed closures to special educational needs and disabilities (SEND) nurseries, with politicians joining the fight to protect vulnerable children. MPs and ...
Frontiers

Parental perceptions and attitudes towards the inclusion of children with neurodevelopmental, physical and sensory disabilities

Parental knowledge and attitudes are key determinants of inclusive education and children’s social participation, yet little is known about how parents conceptualize different types of disabilities.